Israel Englander Puma Biotechnology, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 334,609 shares of PBYI stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
334,609
Previous 1,385,194
75.84%
Holding current value
$1.63 Million
Previous $4.1 Million
72.02%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding PBYI
# of Institutions
124Shares Held
33.1MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.1 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$9.78 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.13 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $222M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...